Minimal residual disease (MRD) testing in newly diagnosed multiple myeloma (MM) patients: A prospective head-to-head assessment of cell-based, molecular, and molecular-imaging modalities Meeting Abstract
| Authors: | Korde, N.; Mailankody, S.; Roschewski, M.; Faham, M.; Kotwaliwale, C.; Moorhead, M.; Kwok, M. L.; Manasanch, E. E.; Bhutani, M.; Tageja, N.; Kazandjian, D.; Costello, R.; Zhang, Y.; Zingone, A.; Burton, D.; Mulquin, M.; Carpenter, A.; Zuchlinski, D.; Lamping, E.; Carter, G.; Morrison, C.; Kurdziel, K.; Lindenberg, M.; Kurlander, R.; Maric, I.; Calvo, K. R.; Braylan, R. C.; Yuan, C.; Stetler-Stevenson, M.; Arthur, D. C.; Steinberg, S. M.; Figg, W. D.; Choyke, P.; Landgren, O. |
| Abstract Title: | Minimal residual disease (MRD) testing in newly diagnosed multiple myeloma (MM) patients: A prospective head-to-head assessment of cell-based, molecular, and molecular-imaging modalities |
| Meeting Title: | 56th Annual Meeting of the American Society of Hematology (ASH) |
| Journal Title: | Blood |
| Volume: | 124 |
| Issue: | 21 |
| Meeting Dates: | 2014 Dec 6-9 |
| Meeting Location: | San Francisco, CA |
| ISSN: | 0006-4971 |
| Publisher: | American Society of Hematology |
| Date Published: | 2014-12-06 |
| Language: | English |
| ACCESSION: | WOS:000349243506062 |
| PROVIDER: | wos |
| DOI: | 10.1182/blood.V124.21.2105.2105 |
| Notes: | Meeting Abstract: 2105 -- 56th Annual Meeting of the American-Society-of-Hematology -- DEC 06-09, 2014 -- San Francisco, CA -- Source: Wos |
Altmetric
Citation Impact
BMJ Impact Analytics
Related MSK Work